Non-coding RNAs in cancer: multi-omics insights, liquid biopsy advances, drug resistance mechanisms, and the road to clinical translation.

Tutar Ş, Rezayifar V, Elhaj HAM, Tutar M, Ataman C, Tutar L

Open source

DOI
10.3389/fonc.2026.1924660
Published
2026
Container
Frontiers in oncology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fonc.2026.1924660,
  title = {Non-coding RNAs in cancer: multi-omics insights, liquid biopsy advances, drug resistance mechanisms, and the road to clinical translation.},
  author = {Tutar Ş and Rezayifar V and Elhaj HAM and Tutar M and Ataman C and Tutar L},
  year = {2026},
  journal = {Frontiers in oncology},
  doi = {10.3389/fonc.2026.1924660},
  url = {https://doi.org/10.3389/fonc.2026.1924660}
}

RIS

TY  - JOUR
TI  - Non-coding RNAs in cancer: multi-omics insights, liquid biopsy advances, drug resistance mechanisms, and the road to clinical translation.
AU  - Tutar Ş
AU  - Rezayifar V
AU  - Elhaj HAM
AU  - Tutar M
AU  - Ataman C
AU  - Tutar L
PY  - 2026
JO  - Frontiers in oncology
DO  - 10.3389/fonc.2026.1924660
UR  - https://doi.org/10.3389/fonc.2026.1924660
ER  - 

APA

Ş, T., V, R., HAM, E., M, T., C, A., & L, T. (2026). Non-coding RNAs in cancer: multi-omics insights, liquid biopsy advances, drug resistance mechanisms, and the road to clinical translation.. Frontiers in oncology. https://doi.org/10.3389/fonc.2026.1924660

Source records